10
Participants
Start Date
November 23, 2016
Primary Completion Date
June 6, 2019
Study Completion Date
June 6, 2019
25% Mannitol
"Route of administration:~In this study, the first step of the treatment will be performing osmotic blood-brain-barrier disruption with administration of intra-arterial 25% Mannitol into the appropriate cervical artery."
Low-dose Intra-arterial Bevacizumab
"Route of administration:~In this study, the second step of the treatment will be administering intra-arterial targeted bevacizumab into the appropriate cervical artery."
Norton Brownsboro Hospital, Louisville
University of Kentucky Medical Center, Lexington
Lead Sponsor
University of Kentucky
OTHER
Norton Healthcare
OTHER